Friess Associates’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-9,890
Closed -$850K 82
2022
Q1
$850K Buy
9,890
+5,562
+129% +$457K 0.45% 69
2021
Q4
$354K Buy
+4,328
New +$316K 0.14% 83
2015
Q4
Sell
-135,200
Closed -$4.99M 182
2015
Q3
$4.99M Buy
+135,200
New +$6.99M 0.46% 72
2014
Q4
Sell
-67,000
Closed -$3.98M 166
2014
Q3
$3.98M Buy
+67,000
New +$3.74M 0.34% 72

Other funds holding THC

Friess Associates's THC Position: Q2 2022 in Review

Friess Associates sold out of Tenet Healthcare (THC) in Q2 2022, closing a stake of 9,890 shares — an estimated $850K sold.

Friess Associates first reported a position in THC in Q3 2014 and held it in 4 quarters. The position peaked at $4.99M in Q3 2015. 373 funds tracked by Wall St. Rank hold THC as of Q2 2022.

  • Friess Associates reported no remaining Tenet Healthcare position as of Q2 2022 after selling out during the quarter.
  • Friess Associates sold 9,890 Tenet Healthcare shares in Q2 2022, an estimated $850K.
  • Friess Associates first reported a position in Tenet Healthcare in Q3 2014 and held it in 4 quarters.
  • Friess Associates's Tenet Healthcare position peaked at $4.99M in Q3 2015.
  • 373 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2022.

Based on Friess Associates's 13F filing for Q2 2022, filed 15 Aug 2022.